Carlyle Group Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001527166

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 19 positions · Total reported value $10.00B · Top-10 concentration 99.9% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 21.1% · 0 new · 1 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.3% · vs SPY -18.4% · Prev Value $10.00B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.8% · vs SPY -6.0% · Latest Value $8.36B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Carlyle Group Inc. disclosed 19 equity positions with a combined reported value of $10.00B. The filing implies a focused portfolio: its ten largest positions account for 99.9% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were MDLN ($7.38B), SARO ($2.53B), PHAT ($37.94M). By sector, the heaviest allocations are Health Care 74.2%, Industrials 25.3%. Versus the prior quarter, allocation shifted toward Industrials (+4.7pp) and away from Health Care (-4.7pp).

Versus the prior quarter, Carlyle Group Inc. opened 0 new positions, trimmed 1 and fully exited 3, a turnover rate of 21.1% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q2 2026 were REPX ($530.39K), NBIS ($509.81K), METC ($287.67K).

Of the 3 positions fully exited versus the prior quarter, the largest were CUBE ($8.08M), HTFL ($497.26K), SYRE ($485.23K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • REPX RILEY EXPLORATION PERMIAN IN · $530.39K
  • NBIS NEBIUS GROUP N.V. · $509.81K
  • METC RAMACO RES INC · $287.67K

Fully Exited (vs previous quarter)

  • CUBE CUBESMART · prev qtr: $8.08M
  • HTFL HEARTFLOW INC · prev qtr: $497.26K
  • SYRE SPYRE THERAPEUTICS INC · prev qtr: $485.23K
  • XCUR EXICURE INC · prev qtr: $239.65K

Insider Transactions (Form 4)

Latest Carlyle Group Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

The Carlyle Group was founded in 1987 in Washington, DC by Bill Conway, Dan D'Aniello and David Rubenstein and is one of the largest alternative asset managers in the world. It listed on Nasdaq (CG) in 2012.

Firm Snapshot

It runs three segments: Global Private Equity, Global Credit and Carlyle AlpInvest, its private-funds and secondaries solutions business. The firm describes its model as connecting people, ideas and capital across one network.

Harvey Schwartz has been CEO since 2023.

  • Headquarters: WASHINGTON, DC, United States
  • SEC registration: 801-52462 (status: Approved), registered 1996-08-06
  • Regulatory AUM (Form ADV): $200.75B as of 2026-07-07
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 314 private funds, of which 1 hedge funds

Portfolio Structure

  • 16 positions · $8.36B reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MDLN (MEDLINE INC) at 77.6%
  • Average position size: $522.59M

Sector Tilt

  • Health Care 78.0%
  • Industrials 21.6%
  • Information Technology 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 added, 1 reduced, 3 exited
  • 13 positions unchanged

Reading the 13F

The 13F is a rounding error at Carlyle: most assets are unlisted company equity, private credit and fund interests that 13F never captures. What appears here — listed vehicles and CLO-related holdings — is a side sleeve.

The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The Carlyle Group Inc. for the 2026-Q2 appears to maintain a conservative and diversified investment approach, with a focus on stability and long-term growth across different sectors. 2. Key Moves: - New Positions: Three new positions were added, including SunPower Inc. (SPWR), which was a significant addition with a 441.1% increase in shares from the previous quarter. - No Reductions: There were no holdings reduced, indicating a retention of existing investments. - No Significant Changes: Most holdings remained the same with no changes in the number of shares. 3. Portfolio Structure: - Passive vs. Active: The portfolio seems to lean towards a passive approach, with a high concentration of 'Hold' actions and no clear trend of active trading. - Sector Bias: The portfolio is well-diversified across sectors, with a significant focus on Health Care (two of the top three holdings) and Industrials (one of the top three holdings). - Risk Appetite: The risk appetite appears moderate, with no aggressive additions or subtractions from positions. 4. Per-Holding One-Liner: - MDLN: Health care sector investment in MEDLINE INC. - SARO: Investment in STANDARDAERO INC, an industrial company. - PHAT: Health care sector investment in PHATHOM PHARMACEUTICALS INC. - INVH: Financial sector investment in INVITATION HOMES INC. - PONY: Technology sector investment in PONY AI INC. - GETY: Information Technology sector investment in GETTY IMAGES HOLDINGS INC. - SPRB: Health care sector investment in SPRUCE BIOSCIENCES INC. - SPWR: Information Technology sector investment in SUNPOWER INC (significant increase). - ACET: Health care sector investment in ADICET BIO INC. - FWRD: Industrials sector investment in FORWARD AIR CORP. 5. One-Sentence Style Summary: Carlyle Group Inc. for 2026-Q2 maintained a conservative, diversified portfolio with a focus on Health Care and Industrials sectors, adding a significant position in SunPower Inc. while holding steady on the rest of its investments.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 74.2%
Industrials 25.3%
Financials 0.2%
Technology 0.2%
Energy 0.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 187.08M $7.38B 73.78%
73.78%
Hold
2 84.59M $2.53B 25.30%
25.30%
Hold
3 3.50M $37.94M 0.38%
0.38%
Hold
4 662.90K $20.03M 0.20%
0.20%
Hold
5 2.36M $16.42M 0.16%
0.16%
Hold
6 6.23M $5.36M 0.05%
0.05%
Hold
7 38.62K $2.09M 0.02%
0.02%
Hold
8 2.34M $1.61M 0.02%
0.02%
Add
9 184.29K $1.59M 0.02%
0.02%
Hold
10 107.21K $1.45M 0.01%
0.01%
Hold
11 269.89K $1.23M 0.01%
0.01%
Hold
12 340.75K $1.20M 0.01%
0.01%
Hold
13 60.36K $769.02K 0.01%
0.01%
Reduce
14 16.09K $530.39K 0.01%
0.01%
New
15 1.85K $509.81K 0.01%
0.01%
New
16 4.73K $474.62K 0.01%
0.01%
Add
17 1.07M $448.87K 0.00%
0.00%
Hold
18 93.73K $344.00K 0.00%
0.00%
Hold
19 21.74K $287.67K 0.00%
0.00%
New

FAQ

What did Carlyle Group Inc. buy in 2026-Q2?

In its 2026-Q2 13F filing, Carlyle Group Inc. reported 19 equity positions worth $10.00B in aggregate; its largest disclosed positions were MDLN ($7.38B), SARO ($2.53B), PHAT ($37.94M).

How large is Carlyle Group Inc.'s portfolio?

Carlyle Group Inc. reported $10.00B of long equity holdings across 19 positions as of 2026-Q2. Top-10 holdings account for 99.9% of reported value.

What is Carlyle Group Inc.'s investment style?

HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/carlyle/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →